The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Cooler US CPI provides shot in the arm for stocks

Wed, 10th Aug 2022 16:57

(Alliance News) - Stocks in London were buoyed on Wednesday by softening US inflation, raising hopes that the Federal Reserve will be less aggressive in its tightening when it meets next month.

"We don't often get pleasant surprises surrounding the US inflation data so July's numbers are something to be cherished," said ING.

The FTSE 100 index closed up 18.96 points, or 0.3%, at 7,507.11. The FTSE 250 ended up 385.60 points, or 1.9%, at 20,298.00, and the AIM All-Share closed up 5.03 points, or 0.6%, at 919.78.

The Cboe UK 100 ended up 0.4% at 750.90, the Cboe UK 250 closed up 2.1% at 17639.76, and the Cboe Small Companies ended up 0.3% at 14334.41.

In European equities on Wednesday, the CAC 40 in Paris ended up 0.5%, while the DAX 40 in Frankfurt ended up 1.2%.

Wednesday started off slow for stocks in Europe, posting modest losses, but US inflation data released in the afternoon saw major indices spike.

Annually, US consumer prices were up 8.5% in July, slowing from the 9.1% rise seen in June. Market consensus, according to FXStreet, had seen inflation easing only to 8.7% for July.

Versus the previous month, July's prices were entirely flat, slowing from the 1.3% rise in June and behind the market consensus of 0.2%.

Stripping out food and energy, prices were up 0.3% in July from the month before, which the US government noted was a smaller increase recorded in April, May, or June. The July increase matched consensus. On annual basis, core prices rose 5.9%. The annual core CPI rise also was in line with forecasts.

Expectations for the Fed's September meeting were scaled back as analysts digested Wednesday's figures.

On Tuesday, 68% of market participants were expecting the Fed to carry out another 75 basis point rate hike at September's meeting, up from 43% a month before. Following Wednesday's inflation data, however, the probability of a 75 basis point hike stood at just 38%, with the majority view now for the Fed's hiking size to moderate to a half-point.

"This is not yet the meaningful decline in inflation the Fed is looking for. But it's a start and we expect to see broader signs of easing price pressures soon," said Capital Economics.

The dollar fell sharply after US CPI. The pound was quoted at USD1.2253 at the London equities close Wednesday, jumping from USD1.2086 at the close on Tuesday.

The euro stood at USD1.0349 at the European equities close Wednesday, rising against USD1.0223 at the same time on Tuesday. Against the yen, the dollar was trading at JPY132.41, down compared to JPY134.96 late Tuesday.

Gold was quoted at USD1,799.85 an ounce at the London equities close Wednesday, up against USD1,793.82 at the close on Tuesday due to dollar weakness.

Brent oil was quoted at USD94.77 a barrel at the London equities close Wednesday, down from USD97.62 late Tuesday.

Stocks in New York roared ahead, with the DJIA soaring 1.7% in late morning trade, the S&P 500 index rising 2.0%, and the Nasdaq Composite jumping 2.5%.

The FTSE 100's gains were more modest, however, on account of the stronger pound holding back the overseas earnings-heavy index.

The blue-chip index was also dragged down by GSK spin-off Haleon, ending down 8.1% at 279.50 pence, with the stock now down 15% from its IPO price of 330p. GSK, which remains a shareholder in Haleon, closed down 5.5%.

Utilities were lower as the risk-on tone shifted investor favour towards growth stocks. Centrica ended down 5.5% and SSE was down 2.4%, while telecommunications firm BT fell 1.3%. In contrast, tech stock and online grocer Ocado rose 6.6%.

At the top of the FTSE 100 was Admiral, rising 13%, with the insurer reporting a "solid set" of resuts despite a first-half profit fall.

Revenue in the six months to June 30 rose 5.7% year-on-year to GBP1.85 billion from GBP1.75 billion. Total UK premiums written, which comprises its motor, home and travel insurance units, was 2.8% higher year-on-year at GBP1.27 billion from GBP1.23 billion.

Group pretax profit fell 48% year-on-year to GBP251.3 million from GBP482.2 million. Compared to pre-Covid times, however, pretax profit was up 19%. Pretax profit was in line with consensus, broker Peel Hunt noted.

Fellow insurer Aviva rallied 12% as it unveiled plans for a share buyback amid confidence in its prospects.

In the six months to June 30, its IFRS loss widened to GBP633 million from a GBP198 million loss a year prior. Aviva explained that this "largely" reflects adverse market movements and has no impact on capital or cash remittances. Adjusted operating profit rose 14% to GBP829 million from GBP725 million.

Aviva declared an interim dividend of 10.3p per share, rising 40% from 7.35p a year earlier, in line with its full year guidance of around 31.0p per share. The interim dividend is worth a total of GBP289 million.

Looking ahead, Aviva said it is confident of its outlook for 2022, despite a challenging market backdrop. The insurer also said it expects to start a share buyback programme when its 2022 full year results are announced.

In the FTSE 250, TP ICAP rose 14% after the interdealer broker saw interim pretax profit more than double to GBP72 million from GBP28 million. TP ICAP upped its dividend by 13% to 4.5p per share from 4.0p a year prior.

4imprint rose 11% after reporting a surge in interim profit and a double-digit rise in interim revenue as total orders increased. The London-based marketer of promotional merchandise booked a 58% rise in revenue to USD515.5 million and pretax profit multiplied to USD43.9 million from USD3.4 million.

Elsewhere, S&U rose 12% after saying both its motor and property bridging divisions continue to outperform its internal expectations.

The motor and property bridge loan provider said its current receivables stand at GBP370 million, up from GBP340 million in May. S&U added that profitability in the six months to July 31 exceeded the same period last year.

In Thursday's UK corporate calendar, there are half-year results from Chilean miner Antofagasta, soft drinks bottler Coca-Cola HBC, gambling firm Entain and investment manager M&G.

The economic calendar has Irish inflation at 1100 BST and US initial jobless claims and producer prices out at 1330 BST.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.